Health
newsGP – ‘Important’ study shows gout medication can halt coronary disease progression – RACGP
The major clinical trial found use of low dose colchicine reduces heart attacks and the need for coronary stenting or bypass surgery by 30%.
News
The major clinical trial found use of low dose colchicine reduces heart attacks and the need for coronary stenting or bypass surgery by 30%.
Coronary heart disease is the leading cause of death in Australia.
The international study, published in The New England Journal of Medicine, examined the effect of low dose colchicine in patients with chronic coronary disease who were already taking established treatments.The two-year randomised, controlled, double-blind trial, led by GenesisCare i…
-
Noosa News7 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News8 hours agoMotorcyclist dies in crash with truck
-
Noosa News22 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
General22 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate